Indian pharma sector needs price hikes, site and IP transfers to tackle US tariff uncertainty: Report

The Indian pharmaceutical industry requires price increases, site and intellectual property (IP) transfers to deal with the prevailing uncertainty in the sector amid US tariffs, according to a report by Systematix Research

Companies